期刊文献+

磁共振弥散成像和血流灌注成像指导尿激酶溶栓治疗的安全性评价 被引量:1

在线阅读 下载PDF
导出
摘要 目的应用磁共振弥散成像和血流灌注成像指导尿激酶溶栓治疗急性脑梗死 ,观察其安全性。方法25例急性脑梗死病人 ,发病时间为6~12h,均进行磁共振弥散成像 (DWI)和血流灌注成像(PWI) ,并且PWI体积>DWI体积 ,给予尿激酶100万U一次静滴溶栓治疗 ,观察溶栓治疗后凝血酶原时间变化及出血并发症发生情况。结果25例急性脑梗死病人尿激酶溶栓治疗无一例颅内出血 ,凝血酶原时间延长后很快恢复。结论磁共振弥散成像和血流灌注成像可以指导发病6~12h的急性脑梗死的尿激酶溶栓 ,临床疗效安全肯定。
出处 《中国微循环》 2003年第2期113-114,共2页 Journal of Chinese Microcirculation
  • 相关文献

参考文献7

  • 1Wardlaw IM, Warlaw CP. Thromblysis in acute ischemic stroke: does it woke[J] ? Stroke. 1993,23:1826~ 1839
  • 2Tong DC, Yanori MA. Integrated diffusion and perfusion weighted MRI in the assessment of hyperacute stroke: correlation with neurologic deficits and conventional MRI[J]. Neurology. 1997,48(2):223 ~ 224
  • 3Rempp KA, Brix G, Wenz F, ct al. Quantification of reginal cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging[J]. Radiology. 1999,193:437 ~ 641
  • 4Warach S, Dashye JF, Edelman RR. Clinical outcome in ischemic stroke predicted by early diffusion- weighted and perfussion magnetic resonannce imaging: a preliminary analysis[J] .J Cereb Blood Flow Metab. 1996, 16: 53 ~ 59
  • 5Overgaard K, Sperline B, Boysen G, et al.Thrornbolytic therapy in acute ischemic stroke[J] .Stroke. 1998,24: 1439~ 1446
  • 6Fisher M, Takano K.The penumbra , therapeutic time window and acute ischemic stroke [ J ]. Clin Neurol. 1998,4:279 ~ 295
  • 7苏镇培.防治脑卒中的紧迫性和可行途径[J].新医学,2000,31(6):326-327. 被引量:14

共引文献13

同被引文献33

  • 1穆雪梅.脑梗死出血性转化相关因素的分析[J].医学理论与实践,2006,19(11):1291-1292. 被引量:4
  • 2Bayramoglu M, Karatas M, Leblebici B, et al. Hemorrhagic transformation in stroke patients [ J ]. Am J Phys Med Rehabil, 2003, 82(1) :48 -52.
  • 3Demchuk AM, Morgenstern LB, Krieger DW, et al. Serum glucose level and diabetes predict tissue plasminogen activator - related intracerebral hemorrhage in acute ischemic stroke [ J ]. Stroke, 1999,30( 1 ) :34 -39.
  • 4Vatankhah B, Dittmar MS, Fehm NP, et al. Thrombolysis for stroke in the elderly [ J ]. J Thromb Thrombolysis, 2005,20 ( 1 ) : 5 -10.
  • 5Berrouschot J, Rother J, Glahn J,et al. Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old ( > or = 80 years) stroke patients [ J ]. Stroke,2005,36 ( 11 ) :2421 - 2425.
  • 6Ribo M, Montaner J, Molina CA, et al. Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator [ J ]. Stroke ,2004,35 ( 9 ) :2123 - 2127.
  • 7Trouillas P, Derex L, Philippeau F, et al. Early fibrinogen degradation coagulopathy is predictive of parenchymal hematomas in cerebral rt-PA thrombolysis: a study of 157 cases [ J]. Stroke, 2004,35 (6) : 1323 - 1328.
  • 8Bang OY, Saver JL, Liebeskind DS, et al. Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis[ J]. Neurology, 2007,68 (10) : 737 - 742.
  • 9Dzialowski I, Hill MD, Coutts SB,et al. Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS Ⅱ[ J]. Stroke,2006,37(4) :973 -978.
  • 10Neumann-Haefelin T, Hoelig S, Berkefeld J, et al. Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke[ J]. Stroke,2006,37 (10) :2463 - 2466.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部